Mortality benefit from unrestricted access to clopidogrel: too good to be true?
- PMID: 18268269
- PMCID: PMC2228354
- DOI: 10.1503/cmaj.071592
Mortality benefit from unrestricted access to clopidogrel: too good to be true?
Figures

Comment on
-
Restrictive access to clopidogrel and mortality following coronary stent implantation.CMAJ. 2008 Feb 12;178(4):413-20. doi: 10.1503/cmaj.070586. CMAJ. 2008. PMID: 18268267 Free PMC article.
References
-
- Cannon C. Clopidogrel and percutaneous coronary intervention. Lancet 2002;359:169. - PubMed
-
- Choudhury RP. Clopidogrel and percutaneous coronary interventions [letter]. JAMA 2003;289:1925. - PubMed
-
- Bridges JFP. Clopidogrel and percutaneous coronary interventions [letter]. JAMA 2003;289:1925-6. - PubMed
-
- Suissa S. Immortal time bias in observational studies of drug effects. Pharmacoepidemiol Drug Saf 2007;16:241-9. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical